According to a regulatory filing reported by NTB, cancer treatment developer Thor Medical has officially launched production at its newly constructed full-scale manufacturing facility on Herøya in Porsgrunn. The milestone development drove a 28.10 percent surge in the company’s share price as markets reacted to the commercialization of its radioactive substances used in targeted oncology therapies.
Thor Medical Begins Commercial Production of Cancer Treatment Isotopes
Thor Medical completed construction on its first full-scale manufacturing plant at Herøya in Porsgrunn during April, according to corporate disclosures covered by NTB. The facility is now operational, supplying vital radioactive substances utilized in modern cancer treatments. Investors responded decisively to the operational update, pushing the company’s stock up 28.10 percent in active trading on the Oslo Stock Exchange.
Did you know?
Oslo Børs Closes Up Despite Crude Price Swings
The Oslo Stock Exchange benchmark index (Hovedindeksen) finished the week up nearly 2 percent overall, despite a late-session dip during Friday trading that left the final daily gain at 0.18 percent, based on market data compiled by NTB. Throughout the week, trading on the exchange closely tracked fluctuations in international crude markets. North Sea Brent crude opened the week trading at 91,90 dollar fatet per barrel on Monday but dropped over 4 percent to settle at 88,10 dollar per barrel by Friday’s closing bell.
Major equities on the exchange saw mixed results over the weekly trading period. Equinor shares climbed 0.76 percent, DNB gained 0.36 percent, and Kongsberg Gruppen rose 0.44 percent. Conversely, Aker BP slipped 0.03 percent, and telecommunications provider Telenor fell 0.37 percent.
International Technology Stocks and Asian Market Rebound
Global technology equities experienced severe turbulence over the week, with semiconductor shares taking the heaviest losses on international exchanges. However, sentiment shifted sharply on Thursday when the Nasdaq technology index on Wall Street rallied 2.78 percent. The momentum carried over into Asian markets by Friday morning, where South Korea’s Kospi index surged over 18 percent, according to market reports cited by NTB. The regional rally was fueled by massive gains among memory chip giants SK Hynix and Samsung Electronics, both of which climbed nearly 30 percent. On the Oslo Stock Exchange, Nordic Semiconductor shares managed a modest gain of 0.06 percent.
Orkla Expands Confectionery Portfolio With European Acquisition
Oslo Børs-listed industrial and consumer goods conglomerate Orkla has agreed to acquire The European Candy Group (CCI), recognized as one of Europe’s largest producers of vegan confectionery, as reported by NTB. Following the announcement, Orkla shares experienced a slight decline of 0.47 percent.
Frequently Asked Questions
What products does Thor Medical manufacture at its Herøya facility?
According to corporate filings cited by NTB, Thor Medical manufactures radioactive substances utilized in advanced cancer treatments.
How much did Orkla pay to acquire The European Candy Group?
How did the price of Brent crude oil move during the week?
North Sea Brent crude dropped over 4 percent over the course of the week, sliding from 91,90 dollar fatet per barrel on Monday morning to 88,10 dollar per barrel at Friday’s close, according to market data.
What drove the sharp rise in South Korea’s Kospi index?
According to market reports covered by NTB, the Kospi index surged over 18 percent after major memory chip manufacturers SK Hynix and Samsung Electronics recorded gains of nearly 30 percent.
What are your thoughts on Thor Medical’s commercial production launch and Orkla’s expansion into the vegan candy market? Share your perspective in the comments below, or subscribe to our financial newsletter for daily updates on the Oslo Stock Exchange.
Keep reading